L-dopa-induced Dyskinesia
📧 Sign up to get email alerts when something new happens for L-dopa-induced Dyskinesia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AFQ056 to reduce L-dopa-induced dyskinesias in Parkinson disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients [Phase 2]
Phase 2 trial assessing the efficacy and safety of AFQ056 to reduce L-dopa-induced dyskinesias in Parkinson's disease has completed.